Ahmed Zahlan - Author

Ahmed Zahlan

Contributor, The Yuan

Ahmed Zahlan is a Fulbright Visiting Scholar at Columbia Business School, where he is conducting his PhD research on AI healthcare startups. Zahlan is recognized for his groundbreaking work on Glutect, which has earned him several invention prizes, and was named one of the best innovators in Morocco in 2019.

Emerging markets

The Middle East and North Africa present unique opportunities for AI startups

Much of the attention surrounding artificial intelligence is focused on China and America, and so the Middle East and North Africa are sometimes overlooked. However, the region holds many unique opportunities that merit further investigation, stresses Fulbright Scholar Ahmed Zahlan.

Ahmed Zahlan | Dec 07, 2024

New era

A guide for professors to integrate generative AI in teaching

Few industries have felt the disruption of GenAI more than education - and this is true for both teaching and learning. Teachers and professors must therefore learn to take advantage of its positive aspects while mitigating negative ones, argues Fulbright Scholar Ahmed Zahlan.

Ahmed Zahlan | Nov 30, 2024

Domain knowledge

Quantum tech in healthcare is pushing boundaries and improving lives

Most people have only a limited understanding of quantum tech, and even those with more expertise usually do not associate it with healthcare applications. This field is deserving of more attention, however, as it becomes more impactful, argues Fulbright Scholar Ahmed Zahlan.

Ahmed Zahlan | Nov 25, 2024

Optimization

Data, infrastructure barriers hamper AI's cure of Africa's healthcare woes

Africa will gain the most from AI’s activation in healthcare, but the road to fulfilling this vision is a rocky one. Fulbright Scholar Ahmed Zahlan, who is pursuing his PhD in AI healthcare startups, charts the path the second most populous continent must take to reach this goal.

Ahmed Zahlan | May 08, 2024

Domain knowledge

AI is advancing preventive medicine, promoting better health

AI draws much attention for transforming areas of healthcare such as cancer treatments and surgery, but its greatest impact lies in keeping more people healthy so they do not need such intervention, argues Ahmed Zahlan, a Fulbright Scholar doing his PhD on AI healthcare startups.

Ahmed Zahlan | Mar 15, 2024

Emerging markets

AI healthcare startups are already having a transformative impact

Most AI-driven healthcare startups are not household names, yet their impact is far from negligible. Ahmed Zahlan, a Fulbright Scholar doing his PhD on AI healthcare startups at the Columbia Business School, assesses the situation and drops some names to keep an eye on.

Ahmed Zahlan | Nov 02, 2023

Emerging markets

Cutting edge technology is driving financial savings for AI in healthcare

Efforts to reform US healthcare have failed to address the causes of its ills - fragmentation, exorbitant costs, inefficiency, fraud, and waste. Ahmed Zahlan, a Fulbright Scholar doing his PhD on AI healthcare at Columbia Business School, offers his take on how to set it right.

Ahmed Zahlan | Jul 28, 2023